Professor Berggren is a world-leader within the field of pancreatic islet cell function, survival and cell therapy of diabetes.
As Head of Cell Biology & Experimental Endocrinology and Director of the world-leading Rolf Luft Center for Diabetes and Endocrinology Research at Karolinska Institute (Stockholm), he leads a large team of outstanding basic and clinical research scientists working at the forefront of diabetes research.
He combines this with an active islet research programme at Ulster as Professor of Molecular and Cellular Endocrinology, where he employs new strategies to image islet function and improve islet transplantation outcomes in diabetes.
Professor Berggren has published 502 original scientific papers with > 19,000 citations in the field of cell physiology, signal transduction and experimental diabetes research.
This includes pioneering work on the fundamental mechanisms regulating the stimulus-response coupling in the endocrine pancreas plus seminal contributions within the fields of insulin secreting pancreatic beta cell Ca2+ handling, phosphorylated inositol compounds and insulin receptor operated signalling.
His most recent innovation uses cell imaging techniques to study in real-time the functional pathways of islets transplanted into the anterior chamber of the eye – an immune privileged site which may afford a breakthrough for cell therapy of type 1 diabetes.
Professor Berggren is recipient of many prestigious awards, including membership of the US National Academy of Sciences, and his research is published in the highest-ranking journals with more than 18,000 citations.